Trial intelligence / Profile preview

Dose-finding study of Gliolan for endoscopic mitochondrial oxygen tension measurement

NL-OMON44385Recruiting

Sponsor
Erasmus MC
Start
Mar 2018
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of 5-aminolevulinic acid, sponsored by Erasmus MC. Primary endpoint: Minimum effective dose of Gliolan. Started Mar 2018; status: recruiting.

02

Drugs

5-aminolevulinic acid

Beyond the preview

Go deeper on NL-OMON44385.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON44385.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call